慢性肺炎的超额成本的20年趋势
Joseph Emil Amegadzie1,2, Jeenat Mehareen1, Amir Khakban1
1Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
The European respiratory journal
|October 28, 2024
概括
慢性阻塞性肺病 (COPD) 的经济负担正在上升,原因是患者成本和并发症的增加. 这一趋势凸显出,尽管有预防工作,但COPD的管理面临越来越大的挑战.
科学领域:
- 卫生经济学 卫生经济学
- 肺部病理学 肺部病理学
- 公共卫生 公共卫生
背景情况:
- 慢性阻塞性肺病 (COPD) 的主要危险因素,包括人口老龄化,吸烟和空气污染,正在发生变化.
- 这些人口和环境的变化不可避免地改变了COPD人口负担.
- 该研究旨在确定COPD的过度直接成本,并分析2001年至2020年的趋势.
研究的目的:
- 量化与COPD相关的过度直接医疗成本.
- 检查20年 (2001-2020年) 期间这些超额成本的趋势.
- 确定伴随性疾病对COPD总体经济负担的贡献.
主要方法:
- 使用加拿大不列颠哥伦比亚省的行政健康数据进行了一项回顾性匹配队列研究.
- 医生诊断的COPD患者与非COPD患者相匹配.
- 过度的直接医疗费用是通过分析医院记录,门诊服务,药物和社区护理来计算的,经过调整以考虑并发症.
主要成果:
- 对COPD患者的直接医疗费用为每年9224加元,而非COPD患者的直接医疗费用为3396加元,导致每年5828加元的超额费用.
- 在研究期间 (2001-2020年) 超额成本增加了48%.
- 伴随性疾病占每年患者多余成本的CAD 3588,仅心血管疾病的成本就超过了COPD本身.
结论:
- 慢性肺炎的经济负担正在增加,主要是由伴随性疾病驱动的.
- 每位患者的成本上升和COPD患病率稳定或增加表明疾病的经济影响显著升级.
- 目前的预防和管理策略可能需要重新评估,以应对COPD日益增长的财务负担.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


